NVA237 BID Versus Placebo Twelve-week Efficacy Study
Public ClinicalTrials.gov record NCT01715298. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study serves to determine whether the treatment of patients with stable, symptomatic Chronic Obstructive Pulmonary Disease (COPD) with the investigational drug NVA237 is efficient and safe. The efficacy and safety of the drug will be tested against a placebo treatment. The primary criterion to assess efficacy will be the difference between the serial lung function measurements of patients who have been treated for 12 weeks with NVA237 versus those that have received placebo treatment for 12 weeks. A serial lung function measurement (FEV1 testing) will be conducted and the "area under the curve" will be the measure for the ability to breathe.
Study identification
- NCT ID
- NCT01715298
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 432 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2012 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Dec 2013 (Actual)
- Last update posted
- Mar 11, 2015
2012 – 2013
United States locations
- U.S. sites
- 59
- U.S. states
- 27
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | *See Various Dept.'s* | Arizona | — | — |
| Novartis Investigative Site | Chandler | Arizona | 85224 | — |
| Novartis Investigative Site | Fresno | California | 93726 | — |
| Novartis Investigative Site | Fullerton | California | 92835 | — |
| Novartis Investigative Site | Yorba Linda | California | 92886-7921 | — |
| Novartis Investigative Site | Yorba Linda | California | 92886 | — |
| Novartis Investigative Site | Boulder | Colorado | 80304 | — |
| Novartis Investigative Site | Wheat Ridge | Colorado | 80033 | — |
| Novartis Investigative Site | Lynn Haven | Florida | 32444 | — |
| Novartis Investigative Site | Miami | Florida | 33173 | — |
| Novartis Investigative Site | Port Orange | Florida | 32127 | — |
| Novartis Investigative Site | Winter Park | Florida | 32789 | — |
| Novartis Investigative Site | Conyers | Georgia | 30094 | — |
| Novartis Investigative Site | River Forest | Illinois | 60305 | — |
| Novartis Investigative Site | Skokie | Illinois | 60076 | — |
| Novartis Investigative Site | Evansville | Indiana | 47714 | — |
| Novartis Investigative Site | Lexington | Kentucky | 40509 | — |
| Novartis Investigative Site | Sunset | Louisiana | 70584 | — |
| Novartis Investigative Site | Fall River | Massachusetts | 02720 | — |
| Novartis Investigative Site | North Dartmouth | Massachusetts | 02747 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55402 | — |
| Novartis Investigative Site | Plymouth | Minnesota | 55441 | — |
| Novartis Investigative Site | Saint Charles | Missouri | 63301 | — |
| Novartis Investigative Site | St Louis | Missouri | 63128 | — |
| Novartis Investigative Site | St Louis | Missouri | 63141 | — |
| Novartis Investigative Site | Fremont | Nebraska | 68025 | — |
| Novartis Investigative Site | Lincoln | Nebraska | 68510 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68114 | — |
| Novartis Investigative Site | Cherry Hill | New Jersey | 08003 | — |
| Novartis Investigative Site | Albuquerque | New Mexico | 87108 | — |
| Novartis Investigative Site | Brooklyn | New York | 11229 | — |
| Novartis Investigative Site | Brooklyn | New York | 11234 | — |
| Novartis Investigative Site | Great Neck | New York | 11021 | — |
| Novartis Investigative Site | Massapequa | New York | 11758 | — |
| Novartis Investigative Site | New Windsor | New York | 12553 | — |
| Novartis Investigative Site | New York | New York | 10003 | — |
| Novartis Investigative Site | New York | New York | 10028 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45231 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45242 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45245 | — |
| Novartis Investigative Site | Columbus | Ohio | 43213 | — |
| Novartis Investigative Site | Medford | Oregon | 97504-8741 | — |
| Novartis Investigative Site | Medford | Oregon | 97504 | — |
| Novartis Investigative Site | Portland | Oregon | 97213 | — |
| Novartis Investigative Site | Langhorne | Pennsylvania | 19047 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15243 | — |
| Novartis Investigative Site | Pottstown | Pennsylvania | 19464 | — |
| Novartis Investigative Site | Tipton | Pennsylvania | 16684 | — |
| Novartis Investigative Site | East Providence | Rhode Island | 02914 | — |
| Novartis Investigative Site | Fort Mill | South Carolina | 29707 | — |
| Novartis Investigative Site | Rock Hll | South Carolina | 29732 | — |
| Novartis Investigative Site | Denton | Texas | 76210 | — |
| Novartis Investigative Site | San Antonio | Texas | 78229 | — |
| Novartis Investigative Site | Midvale | Utah | 84047 | — |
| Novartis Investigative Site | South Burlington | Vermont | 05403 | — |
| Novartis Investigative Site | Richmond | Virginia | 23219 | — |
| Novartis Investigative Site | Richmond | Virginia | 23233 | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01715298, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2015 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01715298 live on ClinicalTrials.gov.